2023

The United States Department of Justice (DOJ) recently withdrew three policy statements regarding health care antitrust…

Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…

We wrote in 2020 about the hefty fines levied against Novartis and Roche for allegedly engaging in anti-competitive practices with…

The Government Accountability Office (GAO) recently released a report, saying the United States Food and Drug Administration (FDA)…

Recently, the Substance Abuse and Mental Health Services Administration (SAMHSA) published frequently asked questions about the…

Novo Nordisk was recently suspended as a member of the Association of the British Pharmaceutical Industry (ABPI) for two years, as…

The Pennsylvania Department of Human Services recently published a final rule amending the Pennsylvania Human Services Code (the…

The United States Food and Drug Administration (FDA) released draft guidance focused on improving the consistency of information…

A recent report from the Georgetown University Center for Children and Families argues that certain changes and reforms are needed…

The United States Drug Enforcement Administration (DEA) recently published the requirements for training for the Medication Access…